MedTrace Logo

COPD and Inflammatory Mediators

NCT04271124 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2020-02-17

No results posted yet for this study

Summary

Chronic obstructive pulmonary disease (COPD) is widely spread all over the world. It is predicted to be the third leading cause of death by 2020.

Conditions

Interventions

OTHER

exercise training

The patients are allocated to PR+ET group or PR Each group receive an exercise training

Sponsors & Collaborators

  • Faculty of Medicine, Sousse

    lead OTHER

Principal Investigators

  • Yassine Trabelsi, professor · Laboratoire de recherche:Physiologie de l'Exercice et Physiopathologie

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
70 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-31
Primary Completion
2020-07-31
Completion
2020-07-31

Countries

  • Tunisia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04271124 on ClinicalTrials.gov